Literature DB >> 12867641

Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland.

Päivi Laukkanen1,2, Pentti Koskela2, Eero Pukkala1, Joakim Dillner3, Esa Läärä4, Paul Knekt2, Matti Lehtinen2.   

Abstract

Human papillomavirus (HPV) type 16 is the major cause of cervical carcinoma, the incidence of which is decreasing in western countries. In Finland the incidence is, however, increasing in women aged <40 years, but possible underlying changes in HPV-16 epidemiology are unknown. To assess incidence trends of HPV infections, paired sera from a random sample of 8000 women with two pregnancies/sera within 5 years, taken from the serum bank of the Finnish Maternity Cohort (1983-98), were analysed for HPV-6, -11 and -16 antibodies. For 23-31-year-old women, HPV-16 incidence increased over the period 1983-97. HPV-16 seroprevalence increased from 17% in 1983-85 to 24% in 1995-97, but HPV-6 and HPV-11 prevalence was stable at 9-12% throughout the study period. Epidemic spread of the oncogenic HPV-16, but not the non-oncogenic HPV-types, throughout the 1980s and 1990s preceded an increase in the incidence of cervical carcinoma in fertile-aged Finnish women.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867641     DOI: 10.1099/vir.0.18995-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model.

Authors:  Jeffrey N Roberts; Rhonda C Kines; Hormuzd A Katki; Douglas R Lowy; John T Schiller
Journal:  J Natl Cancer Inst       Date:  2011-04-11       Impact factor: 13.506

2.  Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18.

Authors:  Dennis Dias; Jeff Van Doren; Sonela Schlottmann; Sheri Kelly; Derek Puchalski; Wanda Ruiz; Patricia Boerckel; Joseph Kessler; Joseph M Antonello; Tina Green; Martha Brown; Judith Smith; Narendra Chirmule; Eliav Barr; Kathrin U Jansen; Mark T Esser
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

Review 3.  Population-based trends in lung cancer incidence in women.

Authors:  Brian L Egleston; Sibele I Meireles; Douglas B Flieder; Margie L Clapper
Journal:  Semin Oncol       Date:  2009-12       Impact factor: 4.929

Review 4.  Vaccines for cervical cancer.

Authors:  C M Lowndes
Journal:  Epidemiol Infect       Date:  2006-02       Impact factor: 2.451

5.  Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach.

Authors:  Simopekka Vänskä; Kari Auranen; Tuija Leino; Heini Salo; Pekka Nieminen; Terhi Kilpi; Petri Tiihonen; Dan Apter; Matti Lehtinen
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

Review 6.  Aspects of prophylactic vaccination against cervical cancer and other human papillomavirus-related cancers in developing countries.

Authors:  Kari Natunen; Johannes Lehtinen; Proscovia Namujju; John Sellors; Matti Lehtinen
Journal:  Infect Dis Obstet Gynecol       Date:  2011-07-19

Review 7.  The burden of HPV-associated anogenital cancers.

Authors:  Katie Wakeham; Kimberley Kavanagh
Journal:  Curr Oncol Rep       Date:  2014-09       Impact factor: 5.945

8.  Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.

Authors:  Ruanne V Barnabas; Päivi Laukkanen; Pentti Koskela; Osmo Kontula; Matti Lehtinen; Geoff P Garnett
Journal:  PLoS Med       Date:  2006-04-04       Impact factor: 11.069

9.  Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.

Authors:  Mirte Scherpenisse; Madelief Mollers; Rutger M Schepp; Hein J Boot; Chris J L M Meijer; Guy A M Berbers; Fiona R M van der Klis; Hester E de Melker
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

10.  Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples.

Authors:  Catterina Ferreccio; Alejandro Corvalán; Paula Margozzini; Paola Viviani; Claudia González; Ximena Aguilera; Patti E Gravitt
Journal:  BMC Public Health       Date:  2008-02-28       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.